z-logo
open-access-imgOpen Access
Topoisomerase and Tyrosyl-DNA-phosphodiesterase Ratio as an Indicator for the Response of Glioblastoma Cancer to Topoisomerase Targeting Anticancer Drugs
Author(s) -
Wenjie Wang
Publication year - 2019
Language(s) - English
Resource type - Dissertations/theses
DOI - 10.25148/etd.fidc007779
Subject(s) - topoisomerase , irinotecan , glioblastoma , biomarker , chemotherapy , cancer research , temozolomide , topoisomerase inhibitor , cancer , oncology , medicine , dna damage , dna repair , dna , pharmacology , biology , genetics , colorectal cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom